Omnicell, Inc. $OMCL Shares Acquired by Capital Fund Management S.A.

Capital Fund Management S.A. grew its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 97.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 44,713 shares of the company’s stock after buying an additional 22,031 shares during the period. Capital Fund Management S.A. owned 0.10% of Omnicell worth $1,315,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of OMCL. GAMMA Investing LLC increased its holdings in Omnicell by 37.1% in the 2nd quarter. GAMMA Investing LLC now owns 1,694 shares of the company’s stock valued at $50,000 after purchasing an additional 458 shares in the last quarter. AlphaQuest LLC increased its stake in shares of Omnicell by 79.0% in the first quarter. AlphaQuest LLC now owns 6,400 shares of the company’s stock worth $224,000 after buying an additional 2,824 shares during the last quarter. New Age Alpha Advisors LLC acquired a new stake in shares of Omnicell in the 1st quarter valued at about $233,000. EntryPoint Capital LLC raised its stake in Omnicell by 21.6% during the first quarter. EntryPoint Capital LLC now owns 6,671 shares of the company’s stock valued at $233,000 after buying an additional 1,184 shares in the last quarter. Finally, EP Wealth Advisors LLC acquired a new stake in shares of Omnicell during the 1st quarter valued at approximately $245,000. Institutional investors and hedge funds own 97.70% of the company’s stock.

Analyst Ratings Changes

OMCL has been the topic of several research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Omnicell in a research note on Wednesday, October 8th. Piper Sandler reduced their price objective on shares of Omnicell from $57.00 to $55.00 and set an “overweight” rating for the company in a report on Monday, August 11th. Wall Street Zen downgraded Omnicell from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 9th. Finally, Benchmark raised their price objective on shares of Omnicell from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $42.00.

Omnicell Price Performance

Shares of OMCL opened at $39.61 on Friday. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of 92.12, a P/E/G ratio of 5.01 and a beta of 0.83. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.44 and a quick ratio of 1.21. The business’s 50-day moving average is $33.27 and its 200-day moving average is $31.33. Omnicell, Inc. has a fifty-two week low of $22.66 and a fifty-two week high of $47.82.

Insider Buying and Selling at Omnicell

In other news, EVP Corey J. Manley sold 3,880 shares of Omnicell stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $33.25, for a total transaction of $129,010.00. Following the completion of the sale, the executive vice president directly owned 110,653 shares in the company, valued at $3,679,212.25. The trade was a 3.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.52% of the stock is owned by company insiders.

Omnicell Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.